GLG Partners’s PharMerica Corporation PMC Stock Holding History

GLG Partners’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,090	Closed	-$143K	–	503
2016 Q3	$143K	Buy	+5,090	New	+$130K	﹤0.01%	422
2016 Q1	–	Sell	-154,643	Closed	-$5.41M	–	533
2015 Q4	$5.41M	Sell	154,643 -57,722	-27%	-$1.81M	0.17%	148
2015 Q3	$6.05M	Buy	212,365 +80,987	+62%	+$2.72M	0.16%	148
2015 Q2	$4.38M	Buy	131,378 +29,380	+29%	+$902K	0.11%	203
2015 Q1	$2.88M	Buy	+101,998	New	+$2.54M	0.1%	212

Other funds holding PMC

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Partners's PMC Position: Q4 2016 in Review

GLG Partners sold out of PharMerica Corporation (PMC) in Q4 2016, closing a stake of 5,090 shares — an estimated $143K sold.

GLG Partners first reported a position in PMC in Q1 2015 and held it in 5 quarters. The position peaked at $6.05M in Q3 2015. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

GLG Partners reported no remaining PharMerica Corporation position as of Q4 2016 after selling out during the quarter.
GLG Partners sold 5,090 PharMerica Corporation shares in Q4 2016, an estimated $143K.
GLG Partners first reported a position in PharMerica Corporation in Q1 2015 and held it in 5 quarters.
GLG Partners's PharMerica Corporation position peaked at $6.05M in Q3 2015.
166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.